Intercept Pharmaceuticals Price on July 3, 2023

ICPTDelisted Stock  USD 10.31  0.16  1.53%   
If you're considering investing in Intercept Stock, it is important to understand the factors that can impact its price. As of today, the current price of Intercept Pharmaceuticals stands at 10.31, as last reported on the 27th of December, with the highest price reaching 10.50 and the lowest price hitting 10.15 during the day. We have found twenty-three technical indicators for Intercept Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please check out Intercept Pharmaceuticals' Risk Adjusted Performance of (0.11), standard deviation of 5.2, and Market Risk Adjusted Performance of (3.21) to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Intercept Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ICPT
Based on monthly moving average Intercept Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Intercept Pharmaceuticals by adding Intercept Pharmaceuticals to a well-diversified portfolio.

Related Headline

Krystal Biotech Headline on 3rd of July 2023

Filed transaction by Krystal Biotech Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Intercept Pharmaceuticals Valuation on July 3, 2023

It is possible to determine the worth of Intercept Pharmaceuticals on a given historical date. On July 3, 2023 Intercept was worth 11.0 at the beginning of the trading date compared to the closed value of 11.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Intercept Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Intercept Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Intercept Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Intercept Pharmaceuticals' related companies.
 Open High Low Close Volume
  11.23    11.64    11.05    11.06    1,257,439  
07/03/2023
  11.00    11.22    10.98    11.20    496,852  
  11.20    11.25    10.87    11.00    1,154,482  
Backtest Intercept Pharmaceuticals  |  Intercept Pharmaceuticals History  |  Intercept Pharmaceuticals Valuation   PreviousNext  
Open Value
11.0
11.2
Closing Value
11.00
Upside

Intercept Pharmaceuticals Trading Date Momentum on July 3, 2023

On July 05 2023 Intercept Pharmaceuticals was traded for  11.00  at the closing time. The top price for the day was 11.25  and the lowest listed price was  10.87 . The trading volume for the day was 1.2 M. The trading history from July 5, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.79% . The trading delta at closing time against the current closing price is 7.14% .

Intercept Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Intercept Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Intercept Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Intercept financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Intercept Pharmaceuticals Stock history

Intercept Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Intercept is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Intercept Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Intercept Pharmaceuticals stock prices may prove useful in developing a viable investing in Intercept Pharmaceuticals
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company was incorporated in 2002 and is headquartered in New York, New York. Intercept Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 437 people.

Intercept Pharmaceuticals Stock Technical Analysis

Intercept Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Intercept Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Intercept Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Intercept Pharmaceuticals Period Price Range

Low
December 27, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Intercept Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Intercept Pharmaceuticals December 27, 2024 Market Strength

Market strength indicators help investors to evaluate how Intercept Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Intercept Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Intercept Pharmaceuticals stock market strength indicators, traders can identify Intercept Pharmaceuticals entry and exit signals to maximize returns

Intercept Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Intercept Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Intercept Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Intercept to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Consideration for investing in Intercept Stock

If you are still planning to invest in Intercept Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intercept Pharmaceuticals' history and understand the potential risks before investing.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios